www.fdanews.com/articles/142714-qrxpharma-comes-good-on-promise
QRxPharma Comes Good on Promise
December 22, 2011
In a rare achievement for the biotech sector, QRxPharma, the pain-drug developer, has come good on its promise of an alliance with a deep-pocketed partner — and within its nominated December-end time frame.
The Australian
The Australian